Abstract | BACKGROUND:
Diabetic nephropathy (DN) is a major complication of diabetes mellitus, and the most common cause of end-stage renal disease. DN is characterized by early hyperfiltration and renal hypertrophy, which are associated with increased renal insulin-like growth factor-1 (IGF-1) levels. The relationship between IGF-1 and nitric oxide (NO) in DN is not established. The aim of this study was to investigate the effects of NO system modulation on the IGF-1-mediated hypertrophy and hyperfiltration during the first week after diabetes induction. METHODS: RESULTS: STZ induced hyperglycaemia decreased plasma insulin levels and brought about a decrease in body weight. L-NAME administration to diabetic rats significantly prevented renal hypertrophy and hyperfiltration. Serum IGFBP3, IGFBP4 and 30-kDa IGFBP fraction were all significantly reduced in diabetic rats, compared with those in non-diabetic control rats. However, the renal IGFBP1 mRNA expression in diabetic rats was significantly higher. These changes were accompanied by an increased in NO production. L-NAME administration prevented the serum IGFBP decline, without significantly affecting the renal IGFBP1 mRNA expression. CONCLUSIONS: We have shown that increased renal IGF-1 and increased NO production during the very early stages of STZ-induced DN are associated with renal hypertrophy and hyperfiltration in diabetic rats. Modulating the IGF-1 availability to the kidney by nitric oxide synthase inhibition significantly reduced renal hypertrophy and hyperfiltration during the first week of STZ-induced diabetes mellitus.
|
Authors | Nomy Levin-Iaina, Adrian Iaina, Itamar Raz |
Journal | Diabetes/metabolism research and reviews
(Diabetes Metab Res Rev)
Vol. 27
Issue 3
Pg. 235-43
(Mar 2011)
ISSN: 1520-7560 [Electronic] England |
PMID | 21309053
(Publication Type: Journal Article)
|
Copyright | Copyright © 2011 John Wiley & Sons, Ltd. |
Chemical References |
- Insulin-Like Growth Factor Binding Protein 1
- Insulin-Like Growth Factor Binding Proteins
- Nitrogen Oxides
- Nitric Oxide
- Insulin-Like Growth Factor I
- Nitric Oxide Synthase
- NG-Nitroarginine Methyl Ester
|
Topics |
- Animals
- Diabetes Mellitus, Experimental
(metabolism)
- Diabetic Nephropathies
(prevention & control)
- Female
- Hypertrophy
- Insulin-Like Growth Factor Binding Protein 1
(metabolism)
- Insulin-Like Growth Factor Binding Proteins
(metabolism)
- Insulin-Like Growth Factor I
(physiology)
- Kidney
(pathology)
- NG-Nitroarginine Methyl Ester
(pharmacology)
- Nitric Oxide
(physiology)
- Nitric Oxide Synthase
(antagonists & inhibitors)
- Nitrogen Oxides
(metabolism)
- Rats
|